ARCHIVES

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

This article is from The Cancer Letter archive.

Vol. 23 No. 12 | March 28, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000

NCCS Networker Volume 5 Issue 1, Winter 1991

January 13, 1991

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980